Page last updated: 2024-11-02

phenobarbital and Angiomatosis

phenobarbital has been researched along with Angiomatosis in 1 studies

Phenobarbital: A barbituric acid derivative that acts as a nonselective central nervous system depressant. It potentiates GAMMA-AMINOBUTYRIC ACID action on GABA-A RECEPTORS, and modulates chloride currents through receptor channels. It also inhibits glutamate induced depolarizations.
phenobarbital : A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and phenyl groups.

Angiomatosis: A condition with multiple tumor-like lesions caused either by congenital or developmental malformations of BLOOD VESSELS, or reactive vascular proliferations, such as in bacillary angiomatosis. Angiomatosis is considered non-neoplastic.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cheng, LT1
Yeh, MM1
Lu, CC1

Other Studies

1 other study available for phenobarbital and Angiomatosis

ArticleYear
Phenobarbital-Induced Liver Injury With Nodal Angiomatosis.
    Hepatology (Baltimore, Md.), 2019, Volume: 70, Issue:1

    Topics: Adolescent; Angiomatosis; Anticonvulsants; Chemical and Drug Induced Liver Injury; Female; Humans; L

2019